Al-Kahraman Y,Hassan M,Yasinzai Ali D,M Ali D .2010 .Antileishmanial, antimicrobial and antifungal activities of some new aryl azomethines. , 15(2) : 660-671.
Ait-Oudhia K,Gazanion E,Vergnes B,Oury B,Sereno D B .2011 .Leishmania antimony resistance: what we know what we can learn from the field. Parasitol Res., 109(5) : 1225-32.
Almeida O and Santos J .2011 .Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: A systematic literature review. , 86(3) : 497-506.
Antinori S,Schifanella L,Corbellino M .2012 .. Eur. J. Clin. Microbiol, 31(2) : 109.
Bañuls AL,Hide M,Prugnolle F M .2007 .Leishmania and the leishmaniases: A parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv. Parasitol., 64(0) : 1-109.
Benkert P,Biasini M,Schwede T .2011 .Toward the estimation of the absolute quality of individual protein structure models. Bioinfor, 27(3) : 343-350.
Brindley PJ,Kalinna BH,Wong JY,Bogitsh BJ,King LT,Smyth DJ,Verity CK,Abbenante G,Brinkworth RI,Fairlie DP,Smythe ML,Milburn PJ,BielefeldtOhmann H,Zheng Y,McManus DP Y .2001 .Proteolysis of human hemoglobin by schistosome cathepsin D. Mol. , 112(1) : 103-12.
Cruz I,Nieto J,Moreno J,Canavate C,Desjeux P,Alvar J .2006 .Leishmania/HIV co-infections in the second decade. Indi J. Med Res., 123(3) : 357-388.
Desjeux P .2004 .Leishmaniasis: Current situation and new perspectives. Compar. Immunol, 27(5) : 305-318.
Desjeux P and Alvar J .2003 .Leishmania/HIV coinfections: Epidemiology in Europe. Anal. Trop .Medic and Parasitol, 1(Suppl 1) : 3-15.
Dougall A,Alexander B,Holt DC,Harris T,Sultan AH,Bates PA,Rose K,Walton SF K .2011 .Evidence incriminating midages( Diptera: Ceratopogonidae) as potential vectors of Leishmania in Australia. Int. J. Parasitol., 41(5) : 571-579.
Dunn BM .2002 .Structure and mechanism of the pepsinlike family of aspartic peptidases. Chem, 102 : 4431-4458.
Gomez MA,Olivier M .2010 .Proteases and phosphatases during Leishmania-macrophage interaction: Paving the road for pathogenesis. Virulence., 1(4) : 314-318.
Peitsch Guex N,MC Guex N .1997 .SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis, 18(15) : 2714-2723.
Guex N,Diemand A,Peitsch MC .1999 .Protein modelling for all. Trends. Biochem. Sci., 24 : 364-367.
Jabeen F,Oliferenko PV,Oliferenko AA,Pillai GG,Ansari FL,Hall CD,Katritzky AR .2014 .Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis. Eur. J. Med, 80 : 228-242.
Kamhawi S .2006 .Phlebotomine sand flies and Leishmania parasites: Friends or foes? Trends in Parasitol. , 22(9) : 439-45.
Kaye P and Scott P .2011 .Leishmaniasis: Complexity at the host-pathogen interface. Nat Rev. Microbiol., 9, (8) : 604-15.
Lei G,Liu L,Xiong X,Wei Y,Zheng X Y .2008 .New a-amino phenylalanine tetrazole ligand for immobilized metal affinity chromatography of proteins. J. Sep. Sci., 31 : 3002-3008.
Mahmood W,Viberg LT,Fischer K,Walton SF,Holt DC .2013 .An aspartic protease of the scabies mite Sarcoptes scabiei is involved in the digestion of host skin and blood macromolecules. PLoS Negl, 7(11) : 2525.
Morris G M DS,Halliday RS,Huey R,Hart WE,Belew R. K WE,Olson AJ,Comput J. .1998 .Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function. , 19(14) : 1639.
Peitsch MC .1996 .ProMod and Swiss-Model: Internetbased tools for automated comparative protein modelling. Biochem. Soc Trans, 24(1) : 274-279.
Pettersen EF,Goddard TD,Huang CC,Couch GS,Greenblatt DM,Meng EC,Ferrin TE .2004 .UCSF Chimera Visualization System for Exploratory Research and Analysis. J. Comput. Chem, 25(13) : 1605.
Perteguer MJ,Gomez-Puertas P,Caoavate C,Dagger F,Gárate T,Valdivieso E .2013 .Ddi1-like protein from Leishmania major is an active aspartyl proteinase. Cell Str, 18(2) : 171-81.
Pirttimaa M,Nasereddin A,Kopelyanskiy D,Kaiser M,Yli-Kauhaluoma J,Oksman-Caldentey KM,Alakurtti S KM .2016 .Abietane-type diterpenoid amides with highly potent and selective activity against leishmaniadonovani and trypanosomacruzi. J. Nat. Prod, 79(2) : 362-368.
Saleem MM,Werbovetz KA .2006 .. Curr. Med, 13(21) : 2571-2598.
Schubach A,Marzochi MC,Cuzzi-Maya T,Oliveira AV,Araujo ML,Oliveira AL,Marzochi KB .1998 .Cutaneous scars in American tegumentary leishmaniasis patients: A site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Ameri. J. Trop. Medic . Hyg., 58(6) : 824-7.
Schwede T,Kopp J,Guex N,Peitsch MC .2003 .SWISS-MODEL: An automated protein homologymodeling server. Nucleic. Acids. Res., 31(13) : 3381-3385.
Stowe R and Elvey J .2016 .Computer-Aided Drug Design. , 83(5) : 40.
Systèmes BD .2015 .-infections in the second decade. Release, 4 : .
Swenerton RK,Zhang S,Sajid M,Medzihradszky KF,Craik CS,Kelly BL,McKerrow JH .2011 .The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. J. Bio. Chem, 286(1) : 429-40.
Olson Trott O,AJ Trott O .2010 .AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem, 31(2) : 455-461.
Valdivieso E,Dagger F,Rascon A .2007 .Leishmania mexicana: identification and characterization of an aspartyl proteinase activity. Experi, 116(1) : 77-82.
Valdivieso E,Rangel A,Moreno J,Saugar J.M,Cañavate C,Alvar J,Dagger F J .2010 .Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp. , 126(4) : 557-63.
Zhai L,Chen M,Blom J,Teander TG,Christensen SB,Karazmi A .1999 .The antileishmanial acitivity of novel oxygenated chalcones and their mechanism of action. , 43(6) : 793-803.